Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.0 EUR
−13.35 M EUR
27.52 M EUR
11.79 M
About XOMA Royalty Corporation
Sector
Industry
CEO
Owen Patrick Hughes
Website
Headquarters
Emeryville
Founded
1981
XOMA Royalty Corp. operates as a biotech royalty aggregator, which engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with various assets that provides right to future potential royalty and milestone payments. The company was founded by Patrick J. Scannon in 1981 and is headquartered in Emeryville, CA.
Related stocks
<TradeVSA> XOMA - Continue to show strengthStrength in the chart:
1. Confirmation on accumulation
2. Back to previous support
3. Testing resistance
4. Potential to move sideway before breakout
Send us your preference stock to review based on TradeVSA chart by comment at below.
Disclaimer
This information only serves as reference informa
$XOMA KEEP ON WATCH FOR BREAKOUTXoma corp has just received some glowing recommendations, one of which is from H.C Wainwright analyst Joseph Pantginis who has a buy rating with a $30 price target. He wrote,
"We reiterate our Buy rating and $30 target. We highlight that we currently omit the 38 undisclosed partnered assets at the c
See all ideas
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange XOMA ROY. PRF.SH.SER.A 25 stocks are traded under the ticker X0M.
Yes, you can track XOMA ROY. PRF.SH.SER.A 25 financials in yearly and quarterly reports right on TradingView.
XOMA ROY. PRF.SH.SER.A 25 is going to release the next earnings report on Aug 6, 2025. Keep track of upcoming events with our Earnings Calendar.
X0M earnings for the last quarter are 0.06 EUR per share, whereas the estimation was −0.22 EUR resulting in a 125.00% surprise. The estimated earnings for the next quarter are −0.15 EUR per share. See more details about XOMA ROY. PRF.SH.SER.A 25 earnings.
XOMA ROY. PRF.SH.SER.A 25 revenue for the last quarter amounts to 14.71 M EUR, despite the estimated figure of 6.53 M EUR. In the next quarter, revenue is expected to reach 7.97 M EUR.
X0M net income for the last quarter is 2.19 M EUR, while the quarter before that showed −3.83 M EUR of net income which accounts for 157.08% change. Track more XOMA ROY. PRF.SH.SER.A 25 financial stats to get the full picture.
Yes, X0M dividends are paid quarterly. The last dividend per share was 0.46 EUR. As of today, Dividend Yield (TTM)% is 0.00%. Tracking XOMA ROY. PRF.SH.SER.A 25 dividends might help you take more informed decisions.
As of Jul 4, 2025, the company has 13 employees. See our rating of the largest employees — is XOMA ROY. PRF.SH.SER.A 25 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. XOMA ROY. PRF.SH.SER.A 25 EBITDA is −24.29 M EUR, and current EBITDA margin is −139.57%. See more stats in XOMA ROY. PRF.SH.SER.A 25 financial statements.
Like other stocks, X0M shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade XOMA ROY. PRF.SH.SER.A 25 stock right from TradingView charts — choose your broker and connect to your account.